Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging

NCT: NCT04981223 · COMPLETED

NCT IDNCT04981223
StatusCOMPLETED
Start Date2022-04-01
Completion2024-01-26

Brief Summary

The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.

Frequently Asked Questions

What is Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging?

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging is a clinical trial registered under NCT04981223. Current status: COMPLETED.

What is the status of NCT04981223?

The current status of NCT04981223 (Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging) is: COMPLETED.

When did Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging start?

Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging started on 2022-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑